Tandem Diabetes Care, Inc.
TNDM
$14.07
$0.070.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.67% | -17.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.67% | -17.06% | |||
| Cost of Revenue | -1.03% | -7.33% | |||
| Gross Profit | 6.29% | -24.80% | |||
| SG&A Expenses | 4.41% | -0.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.35% | -5.05% | |||
| Operating Income | 7.64% | -5,826.80% | |||
| Income Before Tax | 52.72% | -763,156.25% | |||
| Income Tax Expenses | -162.86% | 1,245.74% | |||
| Earnings from Continuing Operations | 59.86% | -17,392.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.86% | -17,392.19% | |||
| EBIT | 7.64% | -5,826.80% | |||
| EBITDA | 8.92% | -924.00% | |||
| EPS Basic | 60.25% | -17,346.49% | |||
| Normalized Basic EPS | -4.76% | -1,859.69% | |||
| EPS Diluted | 60.25% | -17,346.49% | |||
| Normalized Diluted EPS | -4.76% | -1,868.95% | |||
| Average Basic Shares Outstanding | 0.97% | 0.71% | |||
| Average Diluted Shares Outstanding | 0.97% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||